1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. News
  7. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
Real-time Estimate Cboe Europe  -  07:58 2022-08-11 am EDT
223.95 SEK   +0.92%
07/20Getinge is announcing a medical device field action of HLS Set Advanced products
AQ
07/20Getinge AB Announces Medical Device Field Action of Hls Set Advanced Products
CI
07/19TRANSCRIPT : Getinge AB, Q2 2022 Earnings Call, Jul 19, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Lena Hagman, Executive Vice President Quality compliance, Regulatory & Medical Affairs, leaves Getinge

06/30/2022 | 08:01am EDT

Getinge today announces that Lena Hagman, Executive Vice President Quality compliance, Regulatory & Medical Affairs, has decided to leave Getinge. Lena Hagman will remain in her position and member of the Executive Team until a successor has been appointed.

Lena Hagman has been with the company in various leading positions within Quality, Regulatory and Compliance since 2010. She will continue in her current role until her successor has been appointed, but no longer than December 31, 2022. 

"I would like to thank Lena for her contributions to the company," says Mattias Perjos, President & CEO at Getinge. "Lena has been instrumental in our work to establish quality processes with the patient in focus. I wish her all the best in the future". 

The process to recruit a new Executive Vice President Quality compliance, Regulatory & Medical Affairs of Getinge will commence immediately.

Media contact

Anna Appelqvist, Vice President Corporate Communications
Phone: +46 734 244 527
E-mail: anna.appelqvist@getinge.com

About Getinge
Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving every-day life for people, today and tomorrow.

https://news.cision.com/getinge/r/lena-hagman--executive-vice-president-quality-compliance--regulatory---medical-affairs--leaves-getin,c3594328

https://mb.cision.com/Main/942/3594328/1599337.pdf

(c) 2022 Cision. All rights reserved., source Press Releases - English

All news about GETINGE AB
07/20Getinge is announcing a medical device field action of HLS Set Advanced products
AQ
07/20Getinge AB Announces Medical Device Field Action of Hls Set Advanced Products
CI
07/19TRANSCRIPT : Getinge AB, Q2 2022 Earnings Call, Jul 19, 2022
CI
07/19GETINGE : Presentation Q2 Report 2022
PU
07/19GETINGE INTERIM REPORT JANUARY-JUNE : Recovery in elective surgery overshadowed by extern..
AQ
07/19Getinge AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30..
CI
07/19GETINGE AB : Half-year report
CO
07/14Getinge appoints Agneta Palmér as Executive Vice President Operational Services and mem..
AQ
07/14Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member ..
CI
07/14GETINGE AB : Nomination
CO
More news
Analyst Recommendations on GETINGE AB
More recommendations
Financials
Sales 2022 28 587 M 2 850 M 2 850 M
Net income 2022 3 159 M 315 M 315 M
Net Debt 2022 2 433 M 243 M 243 M
P/E ratio 2022 19,1x
Yield 2022 1,89%
Capitalization 60 439 M 6 026 M 6 026 M
EV / Sales 2022 2,20x
EV / Sales 2023 1,98x
Nbr of Employees 10 986
Free-Float 79,8%
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 221,90 SEK
Average target price 323,33 SEK
Spread / Average Target 45,7%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandstr÷m Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB-43.84%6 026
SHOCKWAVE MEDICAL, INC.55.56%9 967
MASIMO CORPORATION-46.11%8 757
NOVOCURE LIMITED6.41%8 368
PENUMBRA, INC.-39.77%6 557
IRAY TECHNOLOGY COMPANY LIMITED2.13%5 476